Korro Bio, Inc.
KRRO
$8.88+0.79%
End of day · as of Oct 15, 2026, 2:00 AM ET
Mkt cap
$159.80M
EV/Sales
21.6
P/E ratio
N/A
FY2025 Revenue
$6.39M
EPS (TTM)
$-9.88
Gross Margin (FY2025)
N/A
Profit Margin (FY2025)
-1834.48%
Beta
2.23
Div yield
N/A
Sector
Healthcare
Korro Bio, Inc. (KRRO) is a biotechnology company listed on US.
Latest reported KRRO revenue for 2025-12-31 was $6.4M. Net income was -$117.3M. Revenue was up 181.5% from 2024-12-31 to 2025-12-31. KRRO currently screens at market cap $159.8M.
Use this KRRO research hub for sector, financials, and filings — not a live tape.
Latest cached year on this hub. Full KRRO income, balance, and cash tables.
Korro Bio, Inc. (KRRO) is a biotechnology company in the Healthcare sector.
Latest cached Korro Bio, Inc. (KRRO) revenue for Dec 31, 2025 was $6.4M. Net income was -$117.3M. Statements: https://lician.com/financials/krro
Korro Bio, Inc. (KRRO) market capitalization is $159.8M on the latest cached snapshot.
Korro Bio, Inc. (KRRO) cached previous close $8.81; day range $8.62 – $8.92; volume 215,715. Session quote: https://lician.com/quote/krro
Korro Bio, Inc. (KRRO) latest cached earnings event is "KRRO earnings" on Aug 11, 2026. Earnings calendar: https://lician.com/earnings
The latest cached KRRO filing is 8-K · Oct 5, 2026. Filings: https://lician.com/sec/krro